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Sesquiterpenes α-humulene and β-caryophyllene oxide enhance 
the efficacy of 5-fluorouracil and oxaliplatin in colon cancer cells
The present study is designed to find out if sesquiterpenes, 
α-humulene (HUM), valencene (VAL), β-caryphyllene-
oxide (CAO) and trans-nerolidol (NER), are able to improve 
the antiproliferative effect of classical cytostatic drugs, 
5-fluorouracil (FU) and oxaliplatin (1,2-diaminocyclohexa-
neoxalato-platinum, OxPt), in colon cancer cell lines Caco-2 
and SW-620. In addition, the possible mechanisms of ses-
quiterpene action are studied. The results show significant 
ability of HUM and especially of CAO to enhance the anti-
proliferative effects of FU and OxPt in cancer cell lines 
Caco-2 and SW-620. On the other hand, VAL and NER are 
ineffective. The action of CAO could be partly based on its 
ability to disrupt the mitochondrial membrane potential 
and to activate initiator caspases, but other mechanisms are 
probably also involved. Based on these results, CAO seems 
to have the potential for combination therapy of colon can-
cers and deserves further study.
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Despite advances in diagnostics, surgery and targeted therapy, colorectal cancers 
have very high prevalence and mortality, and thus the search for new therapeutic possi-
bilities is of great importance (1). Plants are rich reservoirs of secondary metabolites with 
anti-cancer activities. Especially essential oils and their constituents, terpenes, could be 
proper candidates (2).
Essential oil from the leaves of Myrica rubra (Sieb. et Zucc, Myricaceae, MEO), tradition-
ally used in folk medicine, exhibited significant antiproliferative activity in several intes-
tinal cancer cell lines (3). GC×GC/TOF-MS analysis of MEO identified sesquiterpenes 
β-caryophyllene, α-humulene (HUM), humulene epoxide I, valencene (VAL), epi-α-
selinene, γ-murolene, β-caryophyllene-oxide (CAO) and trans-nerolidol (NER) as major 
compounds (3). In the following studies, antiproliferative and pro-oxidative effects of 
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lines (4, 5). Many other sesquiterpenes possess anticancer activities, mainly based on their 
ability to activate apoptosis, to arrest cell cycle, or to inhibit proangiogenic, invasive and 
proliferative markers (2). In addition, some sesquiterpenes were able to improve the effi-
cacy of classical anticancer drugs when used in combinations. For example, β-caryophyllene 
increased antiproliferative activity of paclitaxel and its intracellular accumulation in sev-
eral cancer cell lines (6). Also CAO improved the efficacy of paclitaxel and doxorubicin in 
human myeloma and prostate cancer cells (7).
In our previous studies, MEO as well as its components CAO, HUM, NER and VAL 
were tested in view of their possible ability to improve the efficacy of doxorubicin (DOX) 
in various cancer cell lines (8). In colon cancer cells Caco-2, MEO enhanced the DOX anti-
proliferative and pro-oxidative effect and increased DOX intracellular concentration. CAO, 
NER and VAL significantly enhanced antiproliferative efficacy of DOX in Caco-2 cells. All 
sesquiterpenes were able to increase DOX accumulation selectively in cancer cells. In ad-
dition, CAO and VAL were able to increase the DOX pro-oxidative effect (4). In DOX-sen-
sitive lymphoblast CCFR/CEM cells, synergism of DOX with CAO and NER was observed. 
On the other hand, sesquiterpenes did not increase DOX efficacy in DOX-resistant CEM/
ADR cells, although they significantly increased accumulation of DOX and rhodamine-123 
(substrate of efflux transporter ABCB1) within cancer cells. A strong synergism of DOX 
with NER, HUM and CAO was found in ovarian cancer cells (5).
Taken together, the results mentioned above show that specific sesquiterpenes from 
MEO have the potential to enhance DOX efficacy in anticancer therapy. The action of these 
sesquiterpenes is based (at least partly) on their ability to increase oxidative stress in can-
cer cells. However, we would like to clarify the mechanism of the pro-oxidative effect of 
these sesquiterpenes and their ability to improve the efficacy of other anticancer drugs 
used in colon cancer therapy. For this reason, the present study was designed to evaluate, 
for the first time, the effects of sesquiterpenes HUM, CAO, NER and VAL on the mitochon-
drial membrane potential and their influence on the efficacy of FU and OxPt in colon ad-
enocarcinoma cells. OxPt, a third-generation platinum compound, is widely used in gas-
trointestinal malignancies. Its main cellular target is DNA, where it forms cross-links. FU, 
a prominent cytostatic for several cancers including colon cancer, is a pyrimidine analog 
that acts as an antimetabolite stopping the synthesis of DNA.
In addition, the most effective sesquiterpene is also studied in view of its possible 
ability to increase the activities of caspases. Cell line CaCo-2 was used since MEO has ex-
erted the highest efficacy against these colon adenocarcinoma cells (3). In the combination 




Individual sesquiterpenes, FU, OxPt, carbonyl cyanide 3-chlorophenylhydrazone 
(CCCP) (all at the highest purity available), Eagle’s minimum essential medium (EMEM), 
Dulbecco’s modified Eagle’s medium (DMEM), N-2-hydroxyethylpiperazine-N′-2-
ethanesulfonic acid (HEPES) buffer, MEM non-essential amino acid solution, Hank’s bal-
anced salt solution, 5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolylcarbocyanine io-
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dide (JC1 dye), 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), 
dithiothreitol (DTT), dimethylsulphoxide (DMSO), penicillin, streptomycin, l-glutamine 
and neutral red were supplied by Sigma-Aldrich (USA). Fetal bovine serum (FBS) and 
gentamicin sulfate were purchased from Invitrogen (UK) and bovine serum albumin 
(BSA) from Fluka, Switzerland. Stock solutions were prepared in dimethyl sulphoxide and 
stored at 4 °C in the dark.
Cell cultures
Human epithelial colorectal adenocarcinoma lines CaCo-2 and SW-620 were pur-
chased from the American Type Culture Collection (ATCC, Manassas, USA). Cells were 
multiplied in three passages, frozen in aliquots and stored in liquid nitrogen. The absence 
of mycoplasma in all cell lines used in the laboratory was periodically checked by com-
mercial analysis in Generi Biotech (Czech Republic). For every set of experiments (lasting 
3–9 weeks), new storage cells were resuscitated. The CaCo-2 cells were cultured in EMEM 
supplemented with 10 % heat-inactivated FBS, 1 % MEM non-essential amino-acid, 1.5 % 
l-glutamine solution and 0.5 % penicillin/streptomycin. Human metastatic colon adeno-
carcinoma SW-620 cells were maintained in DMEM medium supplemented with 10 % 
heat-inactivated FBS and 1 % penicillin/streptomycin. Cells were grown in T-75 cm2 cul-
ture flasks in a humidified atmosphere containing 5 % CO2 at 37 °C.
Tests of cell proliferation
Sesquiterpenes were pre-dissolved in DMSO; the concentration of DMSO in medium 
was 0.1 %. FU and OxPt were pre-dissolved in redistilled water. Cells were cultured in 
96-well plates and exposed to various concentrations of the tested compounds in culture 
medium for 72 hours. In combination tests, concentrations of both substances were chosen 
according to their IC50 values and the tested concentrations represented the multiples of 
these values at a constant ratio. Cells cultured in medium with 0.1 % DMSO without tested 
compounds were used as control cells. Cells cultured in medium with 10 % DMSO (com-
pletely destroyed cells) served as a positive control. The number of viable cells was assayed 
using the neutral red uptake assay (NRU) as described previously (5).
Activity of caspases
Cells were cultured in 96-well plates for 48 hours. The medium was then removed and 
fresh medium with tested compounds was added. After 4, 8, 24-hour exposition, lysis buf-
fer (50 mmol L–1 hydroxyethylpiperazine-N′-2-ethanesulfonic acid, 5 mmol L–1 3-[(3-chol-
amidopropyl)dimethylammonio]-1-propanesulfonate, 5 mmol L–1 dithiothreitol, pH 7.4) 
was added. Cell lysates were frozen and stored in a freezer (–80 °C) until analysis. Before 
measurement, the samples were thawed. Caspases activities were measured using the 
caspase-GLO assay (Promega, USA) according to the manufacturer s´ manual.
Mitochondrial membrane potential
Cells were cultured in 24-well plates for 24 hours. Then, JC1 dye (final concentration 
5 µmol L–1) was added to the medium. After 30-min incubation, the cells were washed with 
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Hank’s balanced salt solution (HBSS). Tested sesquiterpenes and carbonyl cyanide 3-chlo-
rophenylhydrazone (CCCP) stock solutions, diluted in HBSS, were added to the cells. 
Three concentrations (50, 100, 150 µmol L–1) of sesquiterpenes and three incubation times 
(1, 2 and 4 h) were used. The CCCP served as a positive control. After incubation, the fluo-
rescence was measured and the ratio of fluorescence (590/530 nm) was calculated.
Statistical analysis
The GraphPad Prism 6.0 statistical software was used with statistical significance at 
p < 0.05.
RESULTS AND DISCUSSION
Several mechanisms of anti-cancer activity of sesquiterpenes were considered. One 
could be based on sesquiterpene ability to increase oxidative stress in cancer cells (2). For 
example, bigelovin, a sesquiterpene lactone isolated from Inula helianthus aquatica, has been 
Fig. 1. Effects of sesquiterpenes: a) α-humulene (HUM), b) β-caryophyllene oxide (CAO), c) nerolidol 
(NER) and d) valencene (VAL) on mitochondrial membrane potential (MMP) in Caco-2 cells tested 
using the JC-1 assay. Data (mean ± SD) are expressed as percentage of MMP in untreated cells (control: 
100 %). Significant decrease vs. control: * p < 0.05.
a)                                                                              b)
c)                                                                              d)
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proven to suppress cell proliferation and induce apoptosis in human colorectal cancer HT-
29 and HCT 116 cells via G2/M cell cycle arrest, DNA damage and increase in reactive oxy-
gen species (ROS) (9). Treatment of bladder cancer T24 cells with costunolide resulted in a 
dose-dependent inhibition of cell viability and induction of apoptosis, which was associ-
ated with ROS generation (10). In our previous study, the effect of selected sesquiterpenes 
from MEO on ROS formation was tested in Caco-2 cells (4). CAO and VAL had significant 
pro-oxidative effects, while HUM did not influence ROS formation and NER acted as a 
strong antioxidant. Taking in consideration the structure of CAO and VAL, direct ROS 
generation was unlikely, but there are other mechanisms how sesquiterpenes can induce 
ROS formation (2). One possible mechanism could be based on sesquiterpene-mediated 
disruption of the mitochondrial membrane.
Therefore, the influence of CAO, HUM, NER and VAL on the mitochondrial mem-
brane potential (MMP) was tested in Caco-2 cells using the JC-1 assay. Three concentra-
tions (50, 100, 150 µmol L–1) of sesquiterpenes and three incubation times (1, 2 and 4 hours) 
were used. The carbonyl cyanide 3-chlorophenylhydrazone (CCCP) served as a positive 
control. The results are demonstrated in Fig. 1. 
HUM in 50 µmol L–1 concentration did not affect MMP, while 150 µmol L–1 HUM 
significantly decreased MMP after all incubation times. CAO in all concentrations signifi-
cantly decreased MMP after 1- and 2-h incubation, but its effect was no longer significant 
after 4-h incubation. Incubation of Caco-2 cells with VAL in all concentrations caused a 
significant decrease of MMP. Interestingly, the effect of VAL was stronger after 4-h than 
after 1-h incubation compared to CCCP (positive control) and CAO. NER did not signifi-
cantly disrupt MMP in Caco-2 cells. In the case of CAO and CCCP, longer exposure led 
surprisingly to milder effects. It could indicate that cells are able to deactivate quickly both 
substances (maybe via biotransformation) and to repair damaged membranes. Based on 
these results, we assume that the pro-oxidative effect of CAO and VAL is mediated through 
disruption of mitochondrial membranes. The ability of some other sesquiterpenes to de-
crease MMP has been reported as well (11). For example, cordycepol C triggered a loss of 
MMP in HepG2 cells in a time- and dose-dependent manner.
The main aim of this project was to find out if sesquiterpenes CAO, HUM, VAL and 
NER are able to improve the efficacy of classical cytostatics in colon cancer cells. In our 
previous studies, these sesquiterpenes enhanced the efficacy of the anticancer drug DOX 
in several colon cancer cell lines (4). The present study is designed to evaluate the ability 
of these sesquiterpenes to improve the efficacy of oxaliplatin and 5-fluorouracil, two other 
drugs commonly used in colon cancer cell therapy. The antiproliferative effect of OxPt and 
FU alone and in combinations with individual sesquiterpenes is tested in Caco-2 and SW-
620 cell lines. Experiments are designed according to the recommendation of Chou-Talalay 
(12). The results obtained in Caco-2 cells are presented in Fig. 2.
At higher concentrations, HUM, CAO and VAL in combinations were able to improve 
the efficacy of OxPt in Caco-2 cells compared to OxPt alone. HUM increased OxPt efficacy 
also at lower concentrations, while NER did not affect OxPt efficacy in Caco-2 cells at any 
concentration. FU combinations with CAO showed a stronger antiproliferative effect at all 
concentrations compared to FU alone. All other sesquiterpenes improved FU efficacy in 
Caco-2 cells, but only at the highest concentrations. Moreover, NER and VAL at lower con-
centrations even impaired FU efficacy.
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Fig. 2. The antiproliferative effect of: a) oxaliplatin (OxPt) and b) 5-fluorouracil (FU) alone and in com-
binations with individual sesquiterpenes in Caco-2 cell line. Data (mean ± SD) are expressed as percent-
age of viability of untreated cells (control: 100 %). Significant increase/decrease vs. control: * p < 0.05.
Fig. 4. The effect of β-caryophyllene oxide (CAO) on the activities of: a) caspases 3/7, b) caspase 8 and 
c) caspase 9 in Caco-2 cells, after 4-, 8- and 24-h exposition. Data (mean ± SD) are expressed as percent-
age of viability of untreated cells (control: 100 %). Significant increase/decrease vs. control: *p < 0.05.
Fig. 3. The antiproliferative effect of: a) oxaliplatin (OxPt) and b) 5-fluorouracil (FU) alone and in com-
binations with individual sesquiterpenes in SW-620 cell line. Data (mean ± SD) are expressed as per-
centage of viability of untreated cells (control: 100 %). Significant increase/decrease vs. control: *p < 0.05.
a)                                                                             b)
a)                                                                             b)
a)                                                     b)                                                       c)
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As regards SW-620 cells, OxPt in combinations with HUM and CAO had a stronger 
antiproliferative effect than OxPt alone, but NER and VAL were not able to improve OxPt 
efficacy in these cells (see Fig. 3a). HUM and CAO also potentiated the antiproliferative 
effect of FU in SW-620 cells. On the other hand, combinations of FU with VAL (at all con-
centrations) and FU with NER (at one concentration) had a weaker antiproliferative effect 
than FU alone (see Fig. 3b).
Taken together, sesquiterpenes CAO and HUM significantly enhanced the efficacy of 
OxPt and FU in colon cancer cells Caco-2. Moreover, these sesquiterpenes were able to 
improve OxPt and FU efficacy in metastatic cancer cells SW-620. These results are promis-
ing in view of the potential use of CAO and HUM in combination therapy of colon cancers. 
In our previous studies, CAO increased the efficacy of DOX in cancer colon cells Caco-2, 
lymphoblast cells CCFR/CEM, and two cancer ovarian cell lines, while HUM was able to 
enhance DOX efficacy only in ovarian cancer cells (4, 5). On the other hand, NER also im-
proved DOX efficacy in all the cell lines mentioned above, but it did not enhance the effi-
cacy of FU and OxPt in colon cancer cell lines Caco-2 and SW-620. These results show that 
the ability of individual sesquiterpenes to improve the efficacy of cytostatics significantly 
differs in dependence on cancer cells and the drug used.
Nevertheless, CAO seems to be the most promising and hence it was chosen for fur-
ther experiments. To find out if combinations of CAO with FU or OxPt directed cancer cells 
into apoptosis, the effect of CAO, FU and OxPt alone, and CAO+FU, CAO+OxPt combina-
tions on the activity of the initiating caspases 8 and 9 and also on the effector caspases 3/7 
activity was tested in the Caco-2 cell line (Fig. 4). The activity of selected caspases was 
evaluated after 4-, 8- and 24-h exposure. Incubation of Caco-2 cells with CAO alone caused 
no elevation of caspase activity; caspase 8 was even mildly decreased after 24-hour CAO 
treatment. This finding indicates that CAO action is not caspase-dependent. Another ses-
quiterpene, cordycepol C, did not increase caspase activities either, although it showed a 
significant antiproliferative effect in HepG2 cells (11). On the other hand, telekin induced 
activation of caspase 9 and caspase 3 in HepG-2 cells (13).
In our study, neither FU nor OxPt in concentrations used increased caspase 8 activity. 
On the other hand, when Caco-2 cells were treated for 8 hours with CAO and FU in com-
bination, the activities of both caspases 8 and 9 increased. The combination of CAO with 
OxPt caused an increase of only caspase 9 activities compared to FU or OxPt alone.
CONCLUSIONS
Our results indicate, for the first time, that HUM and especially CAO have significant 
potential to enhance FU- and OxPt-mediated cancer cell killing. The ability of CAO to 
disrupt mitochondrial membranes (leading to possible release of cytochrome c and to an 
increase of oxidative stress) could participate in its action, but further mechanisms are 
probably involved. In conclusion, CAO seems to be the most promising in the enhance-
ment of FU and OxPt efficacy in colon cancer cells and it deserves further study.
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Abbreviations, acronyms, symbols. – ABCB1 – ATP-binding cassette transporter B1, ATP – adenos-
ine triphosphate, CAO – caryophyllene oxide, CCCP – carbonyl cyanide 3-chlorophenylhydrazone, 
CHAPS – 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, DMEM – Dulbecco’s mod-
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ified Eagle s´ medium, DOX – doxorubicin, DTT – dithiothreitol, EMEM – Eagle’s minimum essential 
medium, FBS – fetal bovine serum, FU – 5-fluorouracil, HEPES – hydroxyethylpiperazine-N′-2-
ethanesulfonic acid, HUM – humulene, MEO – essential oil from Myrica rubra leaves, MMP – mito-
chondrial membrane potential, NER – trans-nerolidol, OxPt – oxaliplatin, VAL – valencene.
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